CNR Institutional Research Information System

TESTA, ALESSANDRA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 1.573
NA - Nord America 1.090
EU - Europa 479
SA - Sud America 296
Continente sconosciuto - Info sul continente non disponibili 137
AF - Africa 26
OC - Oceania 4
Totale 3.605
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.010
SG - Singapore 643
CN - Cina 371
BR - Brasile 229
IT - Italia 196
VN - Vietnam 169
HK - Hong Kong 160
FR - Francia 94
KR - Corea 60
BD - Bangladesh 59
NL - Olanda 34
CA - Canada 32
DE - Germania 27
GB - Regno Unito 26
IN - India 23
AR - Argentina 22
JP - Giappone 22
FI - Finlandia 15
CO - Colombia 14
EC - Ecuador 13
MX - Messico 13
ID - Indonesia 12
UA - Ucraina 11
IE - Irlanda 9
IL - Israele 9
JM - Giamaica 9
PL - Polonia 9
IQ - Iraq 8
RU - Federazione Russa 8
SE - Svezia 8
CR - Costa Rica 7
SA - Arabia Saudita 7
ZA - Sudafrica 7
ES - Italia 6
TT - Trinidad e Tobago 6
AL - Albania 5
AT - Austria 5
LT - Lituania 5
TR - Turchia 5
UY - Uruguay 5
AU - Australia 4
EG - Egitto 4
JO - Giordania 4
MY - Malesia 4
PH - Filippine 4
VE - Venezuela 4
DZ - Algeria 3
GR - Grecia 3
HR - Croazia 3
OM - Oman 3
PE - Perù 3
PK - Pakistan 3
PR - Porto Rico 3
PT - Portogallo 3
BO - Bolivia 2
BY - Bielorussia 2
CL - Cile 2
HN - Honduras 2
MA - Marocco 2
NI - Nicaragua 2
PY - Paraguay 2
SN - Senegal 2
UZ - Uzbekistan 2
AZ - Azerbaigian 1
BA - Bosnia-Erzegovina 1
BB - Barbados 1
CI - Costa d'Avorio 1
CU - Cuba 1
CZ - Repubblica Ceca 1
DK - Danimarca 1
DO - Repubblica Dominicana 1
EE - Estonia 1
ET - Etiopia 1
GT - Guatemala 1
IM - Isola di Man 1
KE - Kenya 1
LB - Libano 1
MR - Mauritania 1
MT - Malta 1
NO - Norvegia 1
NP - Nepal 1
PA - Panama 1
RS - Serbia 1
RW - Ruanda 1
SI - Slovenia 1
SK - Slovacchia (Repubblica Slovacca) 1
SO - Somalia 1
TG - Togo 1
TM - Turkmenistan 1
TN - Tunisia 1
TW - Taiwan 1
VI - Stati Uniti Isole Vergini 1
Totale 3.468
Salva come PNG Salva come JPEG
Città #
Singapore 395
Santa Clara 221
Hong Kong 159
San Jose 120
Hefei 103
Ashburn 93
Beijing 81
Lauterbourg 73
Ho Chi Minh City 60
Seoul 58
Los Angeles 53
Hanoi 36
New York 30
São Paulo 22
Dallas 21
Chicago 11
Tokyo 11
Da Nang 10
Frankfurt am Main 10
Helsinki 10
Milan 10
Amsterdam 9
Catania 9
Council Bluffs 9
Warsaw 9
Brasília 8
Dublin 8
Düsseldorf 8
Naples 8
Orem 8
Stockholm 8
Curitiba 7
Minamishinagawa 7
Philadelphia 7
Belo Horizonte 6
Denver 6
Phoenix 6
Rio de Janeiro 6
Biên Hòa 5
Buffalo 5
Guayaquil 5
Ha Long 5
Houston 5
Johannesburg 5
Lappeenranta 5
Montreal 5
Rome 5
San José 5
The Bronx 5
Thái Bình 5
Toronto 5
Vienna 5
Amman 4
Brooklyn 4
Catalão 4
Chennai 4
City of London 4
London 4
Manchester 4
Newark 4
Paternò 4
Quito 4
Riyadh 4
Alexandria 3
Atlanta 3
Bari 3
Bengaluru 3
Bologna 3
Boston 3
Bắc Giang 3
Bắc Ninh 3
Cairo 3
Can Tho 3
Cincinnati 3
Florianópolis 3
Formosa 3
Guarulhos 3
Hialeah 3
Hải Dương 3
Kansas City 3
Kingston 3
Lancaster 3
Lima 3
Lithonia 3
Marseille 3
Miami 3
Montevideo 3
Mosul 3
Mumbai 3
Munich 3
Natal 3
Osaka 3
Poplar 3
Portsmouth 3
Quận Một 3
Salvador 3
Seeb 3
The Dalles 3
Turin 3
Zagreb 3
Totale 1.941
Salva come PNG Salva come JPEG
Nome #
Role of Gut Microbiota in Overweight Susceptibility in an Adult Population in Italy 134
8-hydroxy-2′-deoxyguanosine, a biomarker of oxidative DNA injury, in diabetic kidney disease 130
SerGenCovid19 - Relazione analisi requisiti SerGenCovid19 86
Mutations in the GLA Gene and LysoGb3: Is It Really Anderson-Fabry Disease? 84
Role of kidney function on Nrf2 mRNA levels in type 2 diabetes 82
Long-term blood pressure monitoring by office and 24-h ambulatory blood pressure in renal transplant patients: a longitudinal study 79
Selenoprotein P-1 (SEPP1) as an Early Biomarker of Acute Kidney Injury in Patients Undergoing Cardiopulmonary Bypass 78
Office, standardized and 24-h ambulatory blood pressure and renal function loss in renal transplant patients 76
Prevalence and detection rate of celiac disease in Italy: Results of a SIGENP multicenter screening in school-age children 75
Joint effect of insulin signaling genes on cardiovascular events and on whole body and endothelial insulin resistance 73
A polymorphism in the major gene regulating serum uric acid associates with clinic SBP and the white-coat effect in a family-based study 70
Systematic DNA Study for Fabry Disease in the End Stage Renal Disease Patients from a Southern Italy Area 70
ACE genotype and ACE inhibitors induced renoprotection in chronic proteinuric nephropathies 68
Selenoprotein P-1 (SEPP1) as an Early Biomarker of Myocardial Injury in Patients Undergoing Cardiopulmonary Bypass 67
Effectiveness of apremilast in real life in patients with psoriasis: A longitudinal study 67
Perioperative Marinobufagenin (MBG) Measurement May Improve Acute Kidney Injury Risk Assessment in Patients Undergoing Major Cardiac Surgery: A Proof-of-Concept Study 65
A Genetic Marker of Uric Acid Level, Carotid Atherosclerosis, and Arterial Stiffness: A Family-Based Study 64
Hyperhomocysteinemia and arteriovenous fistula thrombosis in hemodialysis patients 63
The sirtuinl gene associates with left ventricular myocardial hypertrophy and remodeling in two chronic kidney disease cohorts: a longitudinal study 62
Tissue inhibitor of metalloproteinases (TIMP-1), genetic markers of insulin resistance and cardiomyopathy in patients with kidney failure 58
A POLYMORPHISM IN THE SIRT-1 GENE ASSOCIATES WITH CONCENTRIC REMODELLING OF THE LEFT VENTRICLE AND PREDICTS THE LONGITUDINAL EVOLUTION OF THIS ALTERATION BOTH IN STAGE G1-5 CKD PATIENTS AND IN DIALYSIS PATIENTS 57
Association of IL-6 and a functional polymorphism in the IL-6 gene with cardiovascular events in patients with CKD 56
Pro- and anti-inflammatory cytokine gene expression in subcutaneous and visceral fat in severe obesity 55
A polymorphismin a major antioxidant gene (Kelch-like ECH-associated protein1) predicts incident cardiovascular events in chronic kidney disease patients: an exploratory study 54
Synergism between asymmetric dimethylarginine (ADMA) and a genetic marker of uric acid in CKD progression 52
Real-world effectiveness and safety of guselkumab for the treatment of psoriasis: A 6-month prospective study in a series of psoriatic patients 52
Neuropeptide Y receptor Y2 gene polymorphism interacts with plasma neuropeptide Y levels in predicting left ventricular hypertrophy in dialysis patients 47
Plasma cytokines, glomerular filtration rate and adipose tissue cytokines gene expression in chronic kidney disease (CKD) patients. 47
Atherosclerosis and the Glu298Asp polymorphism of the eNOS gene in white patients with end stage renal disease. 46
Mendelian randomization: a new approach to studying epidemiology in ESRD 46
Joint effect of insulin signaling genes on cardiovascular events and on whole body and endothelial insulin resistance. 45
eNOS and Caveolin-1 Gene Polymorphisms Interaction and Intima Media Thickness: A Proof of Concept Study in ESRD Patients. 45
The ENPP1 Q121 variant predicts major cardiovascular events in high-risk individuals: Evidence for interaction with obesity in diabetic patients 43
The rs17384213 polymorphism in the DDAH1 gene is a marker of chronic allograft dysfunction. 42
Association of a polymorphism in a gene encoding a urate transporter with ckd progression 42
Polymorphismes des gènes du système rènine et progression de l'atteinte rènale : une revue critique 41
I polimorfismi del gene ENPP1 si associano ad ipertrofia ventricolare sinistra ed alla funzione sistolica nei pazienti in dialisi. 41
Joint effect of insulin signaling genes on all-cause mortality 40
CMTM8 variants influence BNT162b2 COVID-19 vaccination response by regulating granulocytic/ polymorphonuclear myeloid-derived suppressor cell activity 37
Il polimorfismo T585C del gene del recettore Y2 del Neuropeptide Y (NPY2R) interagisce con i livelli plasmatici di NPY nel predire l'ipertrofia ventricolare sinistra (IVS) nei pazienti in dialisi. 37
Vitamin D Receptor (VDR) gene polymorphism is associated with Left Ventricular (LV) mass and predicts Left Ventricular Hypertrophy (LVH) progression in End-Stage Renal Disease (ESRD) patients 37
An additive effect of endothelial nitric oxide synthase gene polymorphism contributes to the severity of atherosclerosis in patients on dialysis. 36
The E-selectin gene polymorphism and carotid atherosclerosis in end-stage renal disease. 35
The fat-mass and obesity-associated gene (FTO) predicts mortality in chronic kidney disease of various severity 35
Endothelial nitric oxide sinthase (eNOS) polymorphism interacts with asimmetric dimethyl arginine (ADMA) in determining all cause and cardiovascular mortality in patients with ESRD. 34
Genetic polymorphisms of the ?-adrenergic system: Association with essential hypertension and response to ?-blockade 34
ENPP1 Gene Polymorphisms are associated with left ventricular (LV) mass and systolic function in end stage renal disease (ESRD) patients. 34
LOW FT3 AMPLIFIES THE RISK BY HYPERFIBRINOGENEMIA FOR ALL CAUSE AND CARDIOVASCULAR MORTALITY IN ESKD PATIENTS ON DIALYSIS 33
The deletion polymorphism of the angiotensin-converting-enzyme is associated with nephroangiosclerosis 32
The GLU298ASP variant of nitric oxide synthase interacts with asymmetric dimethyl arginine in determining cardiovascular mortality in patients with end-stage renal disease 32
Interazione tra le varianti geniche della Caveolina-1 e dell'ossido nitrico sintetasi nel determinare la severità dell'aterosclerosi carotidea nei pazienti in dialisi. 31
Insulin resistance and left ventricular hypertrophy in end-stage renal disease: association between the ENPP1 gene and left ventricular concentric remodelling. 31
Interazioni tra le varianti geniche dell'ossido nitrico sintetasi e l'ADMA plasmatica nella mortalità cardiovascolare nei pazienti in dialisi 31
Acido urico, polimorfismo del rene SLCA9, ipertensione e aterosclerosi: un potenziale rapporto causale. 30
Chronic proteinuric nephropathies. II. Outcomes and response to treatment in a prospective cohort of 352 patients: differences between women and men in relation to the ACE gene polymorphism 30
Infiammazione sistemica ed espressione genica nel tessuto adiposo sottocutaneo delle citochine infiammatorie nei pazienti con insufficienza renale cronica. 30
Polymorphisms in the genes of the renin system and progression of renal disease: a critical review 30
Tissue inhibitor of metalloproteinases (TIMP-1), genetic markers of insulin resistance and cardiomyopathy in patients with kidney failure. 30
Linkage disequilibrium patterns and tagSNP transferability among European populations. 29
Le componenti funzionali che controllano la sintesi e la degradazione della dimetil-arginina asimmetrica (ADMA) sono espresse nel tessuto adiposo. 28
ACE-genotype and ACE-inhibitors-induced renoprotection in chronic proteinuric nephrophaties 28
Joint effect of insulin signaling genes on cardiovascular events and on whole body and endothelial insulin resistance 28
Valore prognostico della variante Glu298Asp dell'ossido nitrico sintetasi (eNOS) e dell'interazione eNOS-Arginina Asimmetrica (ADMA) nei pazienti in dialisi. 27
The interaction of a common variant of the eNOS gene with asymmetric dimethylarginine (ADMA) in carotid atherosclerosis in end stage renal disease (ESRD). 27
I polimorfismi del gene che regola la sintetasi dell'ossido nitrico contribuiscono all'aterosclerosi nei pazienti in dialisi. 27
Genetic polymorphisms of the beta-adrenergic system: association with essential hypertension and response to beta-blockade. 27
Adipose tissue cytokines, insulin sensitivity, inflammation, and cardiovascular outcome stage renal disease patients. 26
Il polimorfismo T585C del gene del ricettore Y2 del neuropeptide Y (NPY2R) interagisce con i livelli plasmatici di NPY nel determinismo dell'ipertrofia ventricolare sinistra (IVS) nei pazienti in dialisi. 26
Neuropeptide Y receptor Y2 (NPY2R) gene polymorphism is a modifier for the effect of NPY on left ventricular mass index (LVMI) and it is associated with carotid atherosclerosis in end stage renal disease (ESRD) patients. 24
Polymorphisms in the genes of the renin system and progression of renal disease: a critical review. 23
eNOS gene polymorphisms contribute to the severity of carotid atherosclerosis in dialysis patients. 23
The deletion polymorphism of the angiotensin-converting enzyme is associated with nephroangiosclerosis. 23
Il polimorfismo C242T del gene per la subunità p22 dell'NADPH e il rischio cardiovascolare nei pazienti in dialisi. 22
L'allele T della variante GLU298ASP dell'ossido nitrico sintetasi (eNOS) è un fattore predittivo indipendente di aterosclerosi carotidea nei pazienti in dialisi. 22
Studio sulla molecola dell Asymmetric Dimethyl Arginino (ADMA) nei pazienti in dialisi (CREED) 2004. 22
Polymorphisms within the endpthelial nitric oxide synthase gene interact with plasma ADMA in predicting cardiovascular mortality in ESRD patients 22
Progetto Internazionale European LD Pattern Project 2004-2005. 21
Il polimorfismo L554F del gene della E-selettina è associato con l'ispessimento intimale, stenosi e rimodellamento vascolare in pazienti in dialisi. 20
Vitamin D Receptor (VDR) gene polymorphism and LVH in end stage renal disease (ESRD) patients: a longitudinal study. 20
The severity of carotid atherosclerosis is strongly associated with a polymorphism in the E-selectin gene in patients with end stage renal disease (ESRD). 16
Il polimorfismo rs17384213 nel gene ddah1 è un marker di disfunzione cronica del trapianto 8
null 5
Totale 3.605
Salva come PNG Salva come JPEG
Categoria #
all - tutte 12.560
article - articoli 9.616
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 117
Totale 22.293
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2023/202482 0 0 0 0 0 0 0 0 59 0 23 0
2024/20251.164 8 2 84 105 236 24 21 66 73 48 278 219
2025/20261.951 87 210 166 255 322 94 310 130 84 140 104 49
2026/2027408 151 75 182 0 0 0 0 0 0 0 0 0
Totale 3.605